Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent NeuroblastomaM. Emmy M. Dolman, Jan J. Molenaar, Evon Poon et al.|Clinical Cancer Research|2015Cited by 69
Supplementary Materials and Methods from Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent NeuroblastomaM. Emmy M. Dolman, Jan J. Molenaar, Evon Poon et al.|Unknown|2023Cited by 0
Supplementary Figure Legends from Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent NeuroblastomaM. Emmy M. Dolman, Jan J. Molenaar, Rolf W. Sparidans et al.|Unknown|2023Cited by 0
Supplementary figures S1-8 from Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent NeuroblastomaM. Emmy M. Dolman, Jan J. Molenaar, Evon Poon et al.|Unknown|2023Cited by 0
Supplementary Tables S1-3 from Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent NeuroblastomaM. Emmy M. Dolman, Jan J. Molenaar, Evon Poon et al.|Unknown|2023Cited by 0